GlassScriptPhysician profile
Michael J Wilczewski
NPI 1164520367
$1,137.92
in general payments reported to CMS, 2019-2025
16 companies · $127 in 2025
The $127 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $30.83 · 2021: $14.07 · 2022: $160 · 2023: $277 · 2024: $417 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $326.59 | 2023-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $256.80 | 2019-2025 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $150.94 | 2023 | Bexsero, Pediarix |
| Phadia US INC. | $91.65 | 2022 | |
| Merck Sharp & Dohme LLC | $51.97 | 2023-2024 | M-M-R II, Vaxelis, Vaxneuvance |
| Sanofi-Aventis U.S. LLC | $41.19 | 2024 | |
| Neos Therapeutics, LP | $39.72 | 2022-2024 | Cotempla Xr-Odt |
| Sobi, INC | $31.74 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $31.32 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.84 | 2019-2020 | |
| Neurelis, INC. | $20.23 | 2024 | Valtoco |
| Ultragenyx Pharmaceutical INC. | $17.14 | 2023 | |
| Lnhc, INC | $14.58 | 2025 | Zelsuvmi |
| Kaleo, INC. | $12.28 | 2022 | |
| Shire North American Group INC | $11.82 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wilczewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.